Orit Rozenblatt-Rosen
Auto-generated profile, based on publicly available information

Orit Rozenblatt-Rosen

Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2021 in Cell
Verified
Journal Article
Open access
KPKarin Pelka
Karin Pelka
MHMatan Hofree
Matan Hofree
JCJonathan H. Chen
Jonathan H. Chen
SSSiranush Sarkizova
Siranush Sarkizova
JPJoshua D. Pirl
Joshua D. Pirl
NHNir Hacohen
Nir Hacohen
Immune responses to cancer are highly variable, with mismatch repair-deficient (MMRd) tumors exhibiting more anti-tumor immunity than mismatch repair-proficient (MMRp) tumors. To understand the rules governing these varied responses, we transcriptionally profiled 371,223 cells from colorectal tumors and adjacent normal tissues of 28 MMRp and 34 MMRd patients. Analysis of 88 cell subsets and their 204 associated gene expression programs revealed extensive transcriptional and spatial remodeling across tumors. To discover hubs of interacting malignant and immune cells, we identified expression programs in different cell types that co-varied across patient tumors and used spatial profiling to localize coordinated programs.We discovered a myeloid cell-attracting hub at the tumor-luminal interface associated with tissue damage, and an MMRd-enriched immune hub within the tumor, with activated T cells together with malignant and myeloid cells expressing T-cell-attracting chemokines. By identifying interacting cellular programs, we thus reveal the logic underlying spatially organized immune-malignant cell networks.

8 June 2023 in Nature Medicine
Verified
Journal Article
Open access
PDF file
LSLisa Sikkema
Lisa Sikkema
CRCiro Ramírez-Suástegui
Ciro Ramírez-Suástegui
DSDaniel C. Strobl
Daniel C. Strobl
TGTessa E. Gillett
Tessa E. Gillett
LZLuke Zappia
Luke Zappia
FTFabian J. Theis
Fabian J. Theis
Single-cell technologies have transformed our understanding of human tissues. Yet, studies typically capture only a limited number of donors and disagree on cell type definitions. Integrating many single-cell datasets can address these limitations of individual studies and capture the variability present in the population. Here we present the integrated Human Lung Cell Atlas (HLCA), combining 49 datasets of the human respiratory system into a single atlas spanning over 2.4 million cells from 486 individuals. The HLCA presents a consensus cell type re-annotation with matching marker genes, including annotations of rare and previously undescribed cell types. Leveraging the number and diversity of individuals in the HLCA, we identify gene modules that are associated with demographic covariates such as age, sex and body mass index, as well as gene modules changing expression along the proximal-to-distal axis of the bronchial tree. Mapping new data to the HLCA enables rapid data annotation and interpretation. Using the HLCA as a reference for the study of disease, we identify shared cell states across multiple lung diseases, including SPP1+ profibrotic monocyte-derived macrophages in COVID-19, pulmonary fibrosis and lung carcinoma. Overall, the HLCA serves as an example for the development and use of large-scale, cross-dataset organ atlases within the Human Cell Atlas.

29 April 2021 in Nature
Verified
Journal Article
Closed access
PDF file
TDToni M. Delorey
Toni M. Delorey
CZCarly G. K. Ziegler
Carly G. K. Ziegler
GHGraham Heimberg
Graham Heimberg
RNRachelly Normand
Rachelly Normand
YYYiming Yang
Yiming Yang
ARAviv Regev
Aviv Regev

1 May 2020 in Nature Medicine
Verified
Journal Article
Open access
PDF file
MSMichal Slyper
Michal Slyper
CPCaroline B. M. Porter
Caroline B. M. Porter
OAOrr Ashenberg
Orr Ashenberg
JWJulia Waldman
Julia Waldman
EDEugene Drokhlyansky
Eugene Drokhlyansky
ARAviv Regev
Aviv Regev
Single-cell genomics is essential to chart tumor ecosystems. Although single-cell RNA-Seq (scRNA-Seq) profiles RNA from cells dissociated from fresh tumors, single-nucleus RNA-Seq (snRNA-Seq) is needed to profile frozen or hard-to-dissociate tumors. Each requires customization to different tissue and tumor types, posing a barrier to adoption. Here, we have developed a systematic toolbox for profiling fresh and frozen clinical tumor samples using scRNA-Seq and snRNA-Seq, respectively. We analyzed 216,490 cells and nuclei from 40 samples across 23 specimens spanning eight tumor types of varying tissue and sample characteristics. We evaluated protocols by cell and nucleus quality, recovery rate and cellular composition. scRNA-Seq and snRNA-Seq from matched samples recovered the same cell types, but at different proportions. Our work provides guidance for studies in a broad range of tumors, including criteria for testing and selecting methods from the toolbox for other tumors, thus paving the way for charting tumor atlases.

26 October 2017 in Nature
Verified
Journal Article
Closed access
PDF file
OROrit Rozenblatt-Rosen
Orit Rozenblatt-Rosen
MSMichael J. T. Stubbington
Michael J. T. Stubbington
ARAviv Regev
Aviv Regev
STSarah A. Teichmann
Sarah A. Teichmann

20 April 2018 in Science
Verified
Journal Article
Closed access
PDF file
MFMariella G. Filbin
Mariella G. Filbin
ITItay Tirosh
Itay Tirosh
VHVolker Hovestadt
Volker Hovestadt
MSMcKenzie L. Shaw
McKenzie L. Shaw
LELeah E. Escalante
Leah E. Escalante
MSMario L. Suvà
Mario L. Suvà
The cellular composition of H3K27M gliomas: Diffuse midline gliomas with histone H3 lysine27-to-methionine mutations (H3K27M-glioma) are an aggressive type of childhood cancer with few options for treatment. Filbin et al. used a single-cell sequencing approach to study the oncogenic programs, genetics, and cellular hierarchies of H3K27M-glioma. Tumors were mainly composed of cells resembling oligodendrocyte precursor cells, whereas differentiated malignant cells were a smaller fraction. In comparison with other gliomas, these cancers had distinct oncogenic programs and stem cell–like profiles that contributed to their stable tumor-propagating potential. The analysis also identified a lineage-specific marker that may be useful in developing therapies. Science , this issue p. 331